Modeling and Simulation in Biomedical Engineering: Regulatory Science and Innovation for Advancing Public Health

被引：0
作者：
Tina M. Morrison
Joel D. Stitzel
Steve M. Levine
机构：
[1] US Food and Drug Association,Office of Regulatory Science and Innovation
[2] Wake Forest University School of Medicine,undefined
[3] Dassault Systèmes,undefined
来源：
Annals of Biomedical Engineering | 2023年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 5
页数：4
相关论文
共 13 条
  • [1] Cowey CL(2017)Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA Future Oncol. 13 1699-1710
  • [2] Faris O(2017)An FDA viewpoint on unique considerations for medical-device clinical trials N. Engl. J. Med. 376 1350-1357
  • [3] Shuren J(2016)Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia Blood Cancer J. 6 735-737
  • [4] Gökbuget N(2016)Regulatory approval of new medical devices: cross sectional study BMJ 353 2145-2147
  • [5] Marcus HJ(2016)Cancer metabolism pipeline breaks new ground Nat. Rev. Drug Discov. 15 273-286
  • [6] Mullard A(2022)Trends in prescription drug launch prices, 2008–2021 JAMA 327 undefined-undefined
  • [7] Rome BN(2022)Estimated cost of developing a therapeutic complex medical device in the US JAMA Netw. Open 5 undefined-undefined
  • [8] Egilman AC(2019)Estimation of clinical trial success rates and related parameters Biostatistics 20 undefined-undefined
  • [9] Kesselheim AS(undefined)undefined undefined undefined undefined-undefined
  • [10] Sertkaya A(undefined)undefined undefined undefined undefined-undefined
12